Grant - OSE Immunotherapeutics
Investment Firm
Overview
OSE Immunotherapeutics is an integrated biotechnology company focused on inflammatory disease and cancer treatment.
Announced Date
Aug 01, 2023
Funding Type
Grant
Highlights
Location
Europe
Social
Participant Investors
2
| Investor Name |
|---|
 Government of France |
Round Details and Background
OSE Immunotherapeutics raised $220154 on 2023-08-01 in Grant
OSE Immunotherapeutics is an integrated biotechnology company focused on inflammatory disease and cancer treatment.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 09, 2021 |  Debt Financing - OSE Immunotherapeutics | 1 | - | 11.9M |
| Aug 01, 2023 | Grant - OSE Immunotherapeutics | 2 | - | 220.2K |
| Apr 10, 2024 | Grant - OSE Immunotherapeutics | 1 | - | 9.0M |
| Dec 28, 2016 | Post-IPO Equity - OSE Immunotherapeutics | - | 10.7M |
Recent Activity
There is no recent news or activity for this profile.